Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle se… Read more
Veradigm Inc. (MDRX) - Total Liabilities
Latest total liabilities as of September 2022: $513.64 Million USD
Based on the latest financial reports, Veradigm Inc. (MDRX) has total liabilities worth $513.64 Million USD as of September 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Veradigm Inc. - Total Liabilities Trend (1998–2024)
This chart illustrates how Veradigm Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Veradigm Inc. Competitors by Total Liabilities
The table below lists competitors of Veradigm Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SEC Electric Mach Co Ltd
SHG:603988
|
China | CN¥435.32 Million |
|
Hainan Honz Pharmaceutical Co
SHE:300086
|
China | CN¥805.18 Million |
|
Le Travenues Technology Ltd
NSE:IXIGO
|
India | ₹2.69 Billion |
|
Movado Group Inc
NYSE:MOV
|
USA | $252.01 Million |
|
GSR III Acquisition Corp. Unit
NASDAQ:GSRTU
|
USA | $10.07 Million |
|
Hangzhou Star Shuaier Electric Appliance Co Ltd
SHE:002860
|
China | CN¥1.33 Billion |
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
|
China | CN¥1.10 Billion |
|
Shenzhen Lifotronic Technology Co
SHG:688389
|
China | CN¥549.45 Million |
Liability Composition Analysis (1998–2024)
This chart breaks down Veradigm Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Veradigm Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Veradigm Inc. (1998–2024)
The table below shows the annual total liabilities of Veradigm Inc. from 1998 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $487.22 Million | 0.00% |
| 2022-12-31 | $487.22 Million | -52.10% |
| 2021-12-31 | $1.02 Billion | -18.72% |
| 2020-12-31 | $1.25 Billion | -34.84% |
| 2019-12-31 | $1.92 Billion | +19.95% |
| 2018-12-31 | $1.60 Billion | -39.32% |
| 2017-12-31 | $2.64 Billion | +21.52% |
| 2016-12-31 | $2.17 Billion | +71.93% |
| 2015-12-31 | $1.26 Billion | +7.02% |
| 2014-12-31 | $1.18 Billion | -9.33% |
| 2013-12-31 | $1.30 Billion | +22.19% |
| 2012-12-31 | $1.07 Billion | +2.36% |
| 2011-12-31 | $1.04 Billion | +0.56% |
| 2010-12-31 | $1.03 Billion | +310.15% |
| 2009-12-31 | $252.30 Million | +0.01% |
| 2008-12-31 | $252.29 Million | 0.00% |
| 2007-12-31 | $252.29 Million | +56.35% |
| 2006-12-31 | $161.36 Million | +31.67% |
| 2005-12-31 | $122.55 Million | +6.11% |
| 2004-12-31 | $115.48 Million | +327.69% |
| 2003-12-31 | $27.00 Million | +45.70% |
| 2002-12-31 | $18.53 Million | -1.48% |
| 2001-12-31 | $18.81 Million | +30.22% |
| 2000-12-31 | $14.45 Million | +118.40% |
| 1999-12-31 | $6.61 Million | -49.89% |
| 1998-12-31 | $13.20 Million | -- |